Pediatric meningiomas in The Netherlands 1974–2010: a descriptive epidemiological case study by Thuijs, Nikki B. et al.
ORIGINAL PAPER
Pediatric meningiomas in The Netherlands 1974–2010:
a descriptive epidemiological case study
Nikki B. Thuijs & Bernard M. J. Uitdehaag &
Willem J. R. Van Ouwerkerk & Paul van der Valk &
W. Peter Vandertop & Saskia M. Peerdeman
Received: 26 March 2012 /Accepted: 3 April 2012 /Published online: 29 April 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract
Objective The purpose of this study was to review the
epidemiology and the clinical, radiological, pathological,
and follow-up data of all surgically treated pediatric menin-
giomas during the last 35 years in The Netherlands.
Methods Patients were identified in the Pathological and
Anatomical Nationwide Computerized Archive database,
the nationwide network and registry of histopathology and
cytopathology in The Netherlands. Pediatric patients of
18 years or younger at first operation in 1974–2009 with
the diagnosis meningioma were included. Clinical records,
follow-up data, radiological findings, operative reports, and
pathological examinations were reviewed.
Results In total, 72 patients (39 boys) were identified. The
incidence of operated meningiomas in the Dutch pediatric
population is 1:1,767,715 children per year. Median age at
diagnosis was13years (range0–18years). Raised intracranial
pressure and seizures were the most frequent signs at presen-
tation. Thirteen (18 %) patients had neurofibromatosis type 2
(NF2). Fifty-three (74 %) patients had a meningioma World
Health Organization grade I. Total resection was achieved in
35 of 64 patients. Fifteen patients received radiotherapy post-
operatively. Mean follow-up was 4.8 years (range 0–
27.8 years). Three patients died as a direct result of their
meningioma within 3 years. Four patients with NF2 died as
a result of multiple tumors. Nineteen patients had disease
progression, requiring additional treatment.
Conclusion Meningiomas are extremely rare in the pediatric
population; 25 % of all described meningiomas show bio-
logical aggressive behavior in terms of disease progression,
requiring additional treatment. The 5-year survival is
83.9 %, suggesting that the biological behavior of pediatric
menigiomas is more aggressive than that of its adult
counterparts.
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Introduction
Meningiomas account for about one-third of all primary
central nervous system tumors and occur primarily in adults.
In children, however, meningiomas are rare, accounting for
less than 3 % of pediatric brain tumors, and therefore, only
small, retrospective, single-institution series of pediatric
meningiomas have been published. Only very few studies
have analyzed the epidemiology and biological differences
with the adult counterparts, showing quite different charac-
teristics compared to adults.
The revised World Health Organization (WHO) criteria,
with the prognostic significance of newer morphological
variants (i.e., rhabdoid and chordoid tumors), now provide
well-established guidelines for evaluating meningiomas in
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and prognostic importance of childhood cases. Some
authors state that pediatric meningiomas are more aggres-
sive than their adult counterparts; however, there is no
consensus. A major problem in pediatric meningiomas is
the discordance that arises between the histological appear-
ance of the tumor and its biological behavior.
Using the nationwide network and registry of histopathol-
ogy and cytopathology in The Netherlands, Pathological and
AnatomicalNationwideComputerizedArchive(PALGA),we
performed an epidemiological analysis of childhood meningi-
omas in order to establish a better understanding of the be-
havior of these tumors in contrast to those in adults.
Materials and methods
All patients were identified by searching the PALGA data-
base (www.palga.nl), the nationwide network and registry of
histopathology and cytopathology in The Netherlands, after
appropriate institutional medical ethics committee approval
was obtained. The search was conducted from January 1974
(first CT scan available in The Netherlands) to January
2010. All meningiomas (intracranial, intraspinal, and me-
ningiomas outside the central nervous system (CNS)) in
patients 18 years or younger at the time of histological
diagnosis were included. Fibrous histiocytomas, meningeal
melanomas, and angioblastic meningeal tumors were ex-
cluded. Histological subtypes were classified on the basis
of WHO criteria valid at the time of presentation [27].
Meningosarcomas were classified as WHO grade III [4, 28].
Subsequently, all Dutch neurosurgical centers were visit-
ed to retrospectively review in detail the clinical records,
radiological findings, operative reports, and pathological
examinations and to cross check this with the PALGA
database description. Data on gender, age at diagnosis,
medical history, family history, comorbidity, symptoms,
imaging, tumor location, tumor resection grade, histology,
additional treatment, and follow-up were retrieved. Recur-
rence was defined as the appearance of recurrent tumor
tissue at the same location after gross total resection
(GTR) or the growth of residual tumor tissue after subtotal
resection (STR). Time to recurrence was defined as the time
from GTR to radiological reappearance of a new tumor. For
the patients with known follow-up, survival probabilities
were calculated according to the Kaplan–Meier method
and were measured from the date of diagnosis until the date
of last follow-up or death. Estimation of the Dutch pediatric
population was made on the basis of the number of persons
of 18 years or younger in 1992, the median of our time span.
A two-sided probability level of 0.05 was chosen for statis-
tical significance. Statistical analysis was performed using
SPSS for Windows (version 17.0; SPSS, Inc., Chicago, IL).
Results
From 1974 to 2010, one hundred and seventeen entries of
meningioma histology in patients aged 18 years or younger
were identified in the PALGA database. Forty-five cases
were excluded because either the histological diagnosis
was a duplicate (two PALGA registries for the same tumor
in the same patient) or the original histological diagnosis
was changed after immediate revision. The final study group
consisted of 72 patients (Table 1).
Seventy-two pediatric meningiomas were operated upon in
35 years in The Netherlands. This equates to two operated
meningiomas in patients 18 years or younger a year. As 1992
is the median of our time span, a year in which the pediatric
Dutch population consisted of 3,535,430 people [24], the
incidence is 1 per 1,767,715 persons younger than 19 years.
Clinical characteristics
Of the 72 patients, 39 were male, for a male/female ratio of 1.18.
The mean age at diagnosis was 11.8 years (range 0.3–18.8) with
a median age of 12.7 years (interquartile range eight years). Age
did not differ significantly between the two gender groups.
Thirteen (18 %) out of the 72 patients had neurofibroma-
tosis (NF). The NF group was similar to the entire group with
regard to age, resection grade, and location. However, the NF
grouphadafemalepredominance(n08,notsignificant),more
oftenmultiplemeningiomasatpresentation(n07),andshorter
duration of symptoms: mean 5.8 versus 11.7 months (not
significant). No WHO grade III meningiomas and two out of
14WHOgradeIImeningiomaswerepresentinthisNFgroup.
Five patients had meningiomas outside the CNS, located
extracranially in the cranial subcutaneous tissue. Four patients
in this study had previously received radiation of the central
nervous system for medulloblastoma, astrocytoma, ependy-
moma, and Hodgkin’s disease. These four patients had a
WHO grade I meningioma. Two of these four meningiomas
received additional radiotherapy after surgery. One patient suf-
fered neurofibromatosis type 2 (NF2) and had two meningio-
mas at first presentation. One of these meningiomas showed
recurrence and was operated upon 3 years later. Growth of this
tumor and development of two new tumors occurred again
3 years later. The mean latency period between radiotherapy
and the diagnosis of meningioma was 8.5 years (range 4–13).
Presenting symptoms
Median duration of symptoms of the CNS tumors was
5 months (average 11, range 0–72). Although presenting
symptoms depended on tumor location, meningiomas most
often (36 %) presented with signs and/or symptoms of
raised intracranial pressure (headache, vomiting, papille-
dema; n026) or epilepsy (28 %).
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rofibromatosis (café-au-lait spots and Lisch nodules). Three
patients had a cranial deformity as a result of tumor invasion
of the skull. All five patients with a cutaneous meningioma
presented with a lump on the head, which was present since
birth.
Anatomical distribution
The location of tumors at first presentation is presented in
Table 1. The majority of tumors was located at the convexity
(n027). None of the five patients with subcutaneous menin-
giomas showed intracranial invasion. Eight patients had
multiple central nervous system tumors at first presentation,
seven of whom had NF2.
Histology
The distribution of WHO grade is presented in Table 1.
Meningotheliomatous meningioma was the most common
histological subtype (n015). Of the WHO grade II menin-
giomas, clear cell and atypical subtypes were the most
common (n05). Of the six WHO grade III tumors, two were
meningosarcomas, two anaplastic, one hemangioperycital,
and one of a rhabdoid subtype. WHO grade II meningiomas
appeared to occur more in adolescents than in the younger
patients (not significant).
Additional treatment
At first surgery, GTR was accomplished in 35 patients and
STR in 29 patients. Simple decompression was performed in
six patients (Fig. 1). Reasons for simple decompression
were either an inoperable tumor or a planned biopsy. GTR
and STR numbers were achieved in equal percentages
among the various age groups.
Additional surgery within 30 days after first surgery was
performed in five patients. Reasons were dural reconstruc-
tion after cerebral spinal fluid leakage, or placement or
removal of a shunt due to hydrocephalus.
Table 1 Disease progression
and mortality rates among dif-
ferent variables
NA not applicable, NF2 neurofi-
bromatosis type 2, RTH radio-
therapy, WHO World Health
Organization, GTR gross total
resection, STR subtotal resec-
tion, RGND resection grade not
described
aAt first operation
Variable No. of cases Mean follow-up (years) Disease progression n (%) Mortality n (%)
Age (years)
0–5 13 4.7 5 (38) 2 (15)
6–11 19 6.0 7 (37) 0
12–18 40 4.3 7 (18) 5 (13)
Gender
Male 39 4.9 10 (26) 4 (10)
Female 33 4.7 9 (27) 3 (9)
Location
Supratentorial 38 5.0 11 (29) 3 (8)
Infratentorial 13 5.5 4 (31) 4 (31)
Spine 12 4.4 2 (15) 0
Orbit 4 1.9 2 (50) 0
Cutaneous 5 NA NA 0
NF2
Yes 13 7.8 4 (31) 4 (31)
No 59 4.1 15 (25) 3 (51)
RTH history
Yes 4 4.8 2 (50) 0
No 68 5.3 17 (25) 7 (10)
WHO grade
I 53 4.8 15 (28) 4 (8)
II 13 2.7 3 (23) 1 (8)
III 6 9.9 1 (17) 2 (33)
Procedure
a
GTR 35 4.7 6 (17) 0
STR 29 4.0 13 (45) 4 (14)
RGND 8 5.3 0 3 (38)
Total 72 4.9 19 (26) 7 (10)
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to the central nervous system postoperatively (Fig. 1). Mean
dose given was 42.75 cGy (range 13–60). Additional RTH
followed an incomplete resection in ten patients (WHO I n0
7, WHO II n01, WHO III n02) and complete resection in
five (WHO I n01, WHO II n02, WHO III n02). Reasons
for RTH after GTR were recurrence or atypical or malignant
tumor tissue. Three patients received RTH twice. Mean
interval between two sessions of RTH was 5 years (range
1–10 years).
Follow-up
Mean follow-up was 4.8 years (0–27.8 years, Fig. 2a).
Seventy-two patients had 77 meningiomas at first presenta-
tion, of which 76 were removed at first surgery. In total, 72
patients had 93 meningiomas, which were operated upon
105 times.
Of the 105 meningioma removals, 46 meningiomas were
resected totally; 43 were resected subtotally; and in 16
meningiomas, resection grade was not described. Of the 46
meningiomas resected completely, 12 recurred in nine
patients within a mean period of 5.6 years (range 1–26).
Of the 43 meningiomas resected subtotally, 14 showed
significant growth that required reoperation and/or RTH
within 1.5 years (range 0–4).
Time to reoperation was 3.9 years (range 0–26). A flow
chart of treatment sequelae is shown in Fig. 1. Four patients
developed a second meningioma or a neuroectodermal tu-
mor of a variable histological type, e.g., schwannoma,or
ependymoma.
Seven of the 72 patients are known to have died, three as
a direct result of their meningioma and four patients with
NF2 died as a result of multiple tumors. One 13-year-old
patient had pulmonary metastasis of his WHO grade III
meningioma. Mean interval time between diagnosis and
death was 4 years (range 0–14).
The 1- and 5-year overall survival rate of the CNS
meningiomas was 96.0 % (n050) and 83.9 % (n031),
respectively. The progression-free survival after 1 and
5 years was 84.3 % (n051) and 55.6 % (n036), respec-
tively (Fig. 2b).
Discussion
This is the first study describing all cases of operated pedi-
atric meningiomas in one entire country, providing an ex-
cellent opportunity to determine an accurate incidence rate.
It covers all registered pediatric meningioma data from the
past 35 years, and more importantly, it is the third largest
series on pediatric meningioma [13, 21].
Fig. 1 GTR gross total
resection, STR subtotal
resection, OP operation, RGM
resection grade missing, RTH
radiotherapy, WHO World
Health Organization
1012 Childs Nerv Syst (2012) 28:1009–1015With an incidence of 1:1,770,000 in the pediatric popu-
lation in The Netherlands, meningiomas contribute to only a
small proportion of all pediatric tumors. This very low
incidence of childhood meningiomas has been confirmed
in many literature studies [15]. We used 18 years as the
upper age limit. In other papers, the age range varies widely
in the inclusion criteria.
The pediatric literature is based on extensive time periods
during which imaging facilities, pathological criteria, and
surgical advances have led to shifts in multiple variables,
which makes comparison of results difficult. In our series,
there were 19 atypical and malignant meningiomas (26 %),
compared with 2–38 % cited in the literature [5]. In the the
adult population, this percentage is lower: about 10 % of all
meningiomas [1, 6, 8, 22].
A difference between adult and pediatric meningiomas is
the higher percentage of patients with disease progression.
This might even be a considerable underestimation, since
many patients were lost to follow-up. This higher recurrence
rate reflects a more aggressive biological behavior of pedi-
atric meningiomas.
Kotecha et al. have published a meta-analysis of individ-
ual pediatric patient data in 2012. They found an overall
survival after 5 years of 95.0 % in totally resected pediatric
meningiomas. This survival decreases to 77.3 % in subto-
tally resected meningiomas. Notably, in adults, the overall
survival after 5 years is higher compared with the 84 % in
our series and 82 % in the serie of Kotecha et al. [13].
As in adults, the extent of resection is an important
prognostic factor as recurrence-free rates improve signifi-
cantly with an increasing extent of removal [13]. In our
series, however, the 5-year survival rates are clearly lower
(84 %) than those reported in adults (Table 2).
Kotecha et al. demonstrated a key prognostic factor for
progression-free survival. Children who undergo initial
Fig. 2 n067 (excluding cutaneous meningiomas). a Graph demonstrating disease progression. b Graph showing overall survival by WHO grade
Table 2 Adult and pediatric meningioma characteristics
Variable Adult Pediatric
Prevalence 97.5/100,000 [26] 0.06/100,000
a
Male to female ratio 2:1 [26] 1.18:1
a
Location
Most common Convexity Convexity
a
Infratentorial 8 % 20 %
Intraventricular Rare Frequent 11 %
Dural attachment Frequent Rare
Histology subtype
Most common Meningothelial Meningothelial
a
WHO grades II and III 8 % [14]1 9 –32 %
5-year survival
Overall 93 % [25]8 4 %
a
WHO I 96 % 93 %
WHO II 78
9–95 % [19]8 7 %
WHO III 44
9–64 % [19]7 2 %
5-year RFS
WHO I 88–100 % [18]8 1 %
WHO II 48–73 % [9]6 9 %
WHO III 16–61 % [9]4 1 %
RFS relapse-free survival, WHO World Health Organization
aPresent study
Childs Nerv Syst (2012) 28:1009–1015 1013GTR have a significantly better progression-free survival
than those with an initial STR [13], as in our study. This
also accounts that overall survival is also related to location
of the tumor [14, 17].
Most pediatric CNS tumors have a worse prognosis un-
der the age of 6 years. Worse overall survival in this age
group might be explained by congenital tumor development,
which often results in tumors that are more aggressive in
their biological behavior [13].
In our present series, 18 % had neurofibromatosis, which
fits within the range reported in other series [2, 7, 10, 11]. In
our study, NF2-associated meningiomas did not differ sig-
nificantly from sporadic pediatric tumors with regard to
clinicopathological features, but they did have a higher
frequency of multiplicity [12].
What is extraordinary in this series is the number of
meningiomas located outside the CNS. Five out of the 72
meningiomas were seen in the cranial subcutaneous tissue.
Meningiomas of the skin are the rarest of all extracranial
meningiomas and have been reported in the scalp, the fore-
head, and the paravertebral region, where its occurrence is
exceptional [23].
Meningiomas are recognized as the most common long-
term complication following radiotherapy to the CNS [3, 20].
Typically, the latent period for the presentation of such tumors
is 15 to 20 years; however, they may occur as early as 4 years
after radiation treatment [16]. In our study, four patients de-
veloped meningiomas within 13 years after radiation.
The follow-up time of our study is short (mean 4.9 years),
taking into account that the entire study covers 35 years.
Only 31 patients have a follow-up time of 5 years, due to the
retrospective character of this study. Therefore, it is possible
that the recurrence rate is underestimated and biological
behavior is even worse than described.
In conclusion, pediatric meningiomas are very rare com-
pared to their counterparts in adults. With an incidence of
approximately 1:1.8 million operated patients in the pediat-
ric population in The Netherlands, meningiomas contribute
to only a small proportion of all pediatric tumors. Pediatric
meningiomas have a more aggressive biological behavior
compared to those of the adult population with a high
proportion of patients showing disease progression after sur-
gery. Moreover, the 5-year survival rate was only 83.9 %, and
this is probably even an underestimation.
Despite the retrospective character of this study and its
limitations, one can state that biological behavior of pediatric
meningiomas is more aggressive than of the adult counter-
parts. Further research into biomarkers might give insights
into possible explanations for these differences in behavior.
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